Aarti Drugs advances 15% as board approves buyback at Rs 1,000 per share

The board of directors has fixed April 1 as record date for ascertaining the shareholder who will participate in the proposed buyback.

Shares of Aarti Drugs advanced 15 per cent to Rs 785 on the BSE in the intra-day trade on Friday after its board approved buyback of equity shares of the company at Rs 1,000 per share via tender route. The board of directors has fixed April 1 as the record date for ascertaining the shareholder who will participate in the proposed buyback.

The stock of the pharmaceutical company bounced back 17 per cent from the day’s low of Rs 670. At 03:00 pm; it was trading 10.5 per cent higher at Rs 755, as compared to a 1.4 per